What we do
Portfolio
Team
News

Salz Biosciences

Published on: 10 July 2025

Salz Biosciences

Salz Biociences is committed to develop new approaches to combat neurodegenerative diseases.

← MimeCure

Recent Posts

Pharma Connect Capital closed for new investments
September 2022: University of Groningen participates in Pharma Connect Capital
July 2018: Ir. G.J. Smidfonds participates in Pharma Connect Capital.
Unique Northern approach to developing new drugs

About Us

Pharma Connect Capital participates in startup companies located in Groningen, Friesland & Drenthe with a mission to develop new drugs, drug delivery technologies, biomarkers or diagnostics.

Navigate

Contact
News
Team
Portfolio

Contact Us

L.J. Zielstraweg 2
9713 GX Groningen

Phone: +31 (0)6 53 72 60 22
Email: info@pharmaconnectcapital.com

© PharmaConnectCapital 2016 - 2025 - Webdesign & Development by Skitter